Literature DB >> 10673681

Busulfan clearance in renal failure and hemodialysis.

L L Ullery1, J P Gibbs, G W Ames, F M Senecal, J T Slattery.   

Abstract

The impact of hemodialysis on the clearance of busulfan was determined in a patient with chronic renal failure undergoing autologous peripheral stem cell transplantation for non-Hodgkin's lymphoma. The extraction ratio for busulfan across the dialyzer was 0.530 +/- 0.026 at a blood flow of 400 ml/min, which corresponds to a hemodialysis clearance of 2.23 +/- 0.11 ml/min/kg body weight. Apparent oral clearance of busulfan without hemodialysis was 3.38 +/- 0.56 ml/min/kg. Thus, a 4 h hemodialysis session enhanced the apparent oral clearance of busulfan by 65%. We conclude that hemodialysis effectively removes busulfan from circulating blood, but a standard hemodialysis period (ie, 4 h) does not significantly alter busulfan exposure. Bone Marrow Transplantation(2000) 25, 201-203.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10673681     DOI: 10.1038/sj.bmt.1702112

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  2 in total

Review 1.  Plasma concentration monitoring of busulfan: does it improve clinical outcome?

Authors:  J S McCune; J P Gibbs; J T Slattery
Journal:  Clin Pharmacokinet       Date:  2000-08       Impact factor: 6.447

2.  Chemotherapy for non-Hodgkin lymphoma in the hemodialysis patient: A comprehensive review.

Authors:  Hajime Yasuda; Mutsuko Yasuda; Norio Komatsu
Journal:  Cancer Sci       Date:  2021-06-11       Impact factor: 6.716

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.